Retinal Degeneration 3 (RD3) (N-Term) Peptid
RD3
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN982807
Kurzübersicht für Retinal Degeneration 3 (RD3) (N-Term) Peptid (ABIN982807)
Target
RD3
(Retinal Degeneration 3 (RD3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RD3 antibody (Catalog #: ARP55856_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RD3 (Retinal Degeneration 3 (RD3))
-
Hintergrund
-
RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
Alias Symbols: C1orf36, LCA12
Protein Size: 195 -
Molekulargewicht
- 23 kDa
-
Gen-ID
- 343035
-
NCBI Accession
- NM_183059, NP_898882
-
UniProt
- Q7Z3Z2
Target
-
Sie sind hier:
